BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ:KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced that senior management will participate in the following upcoming virtual investor conferences:
Citi’s 15th Annual BioPharma Virtual Conference
Date: Wednesday, September 9, 2020
Time: 2:25 p.m. EDT
Wells Fargo 2020 Virtual Healthcare Conference
Date: Thursday, September 10, 2020
Time: 9:20 a.m. EDT
Morgan Stanley 18th Annual Global Healthcare Conference
Date: Tuesday, September 15, 2020
Time: 3:30 p.m. EDT
A live webcast of the Wells Fargo presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 90 days on Karuna’s website following the conference.
Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care. For more information, please visit karunatx.com.